Welcome
The second UK Interdisciplinary Breast Cancer Symposium was held on Monday 27th and Tuesday 28th January 2020.
The meeting provided all those with an active interest in breast cancer research and treatment an opportunity to consider and discuss how the latest advances may impact upon their and others areas of expertise. Treatment of breast cancer has for many years been dependent on the interaction of professionals from many disciplines. Research into improving our understanding of this complex disease and prospects for improving its prevention and treatment requires interdisciplinary collaboration to make meaningful advances. The meeting included national and international keynote speakers, plenary sessions, oral and poster presentations.
The Organising Committee
Professor Mitch Dowsett
Head of the Academic Department of Biochemistry and Head of the Centre for Molecular Pathology at the Royal Marsden HospitalProfessor Judith Bliss
Professor of Clinical Trials, Institute of Cancer Research, LondonProfessor Charlotte Coles
Reader in Breast Radiation Research at the Cancer Research UK Cambridge Centre, UKMs Lucy Davies
Association Manager, Association of Breast SurgeryMiss Julie Doughty
Consultant Breast Surgeon, Gartnavel General Hospital, GlasgowProfessor Deborah Fenlon
Professor of Nursing at Swansea University, WalesDr Julia Gee
Senior Lecturer, Cardiff University School of Pharmacology and Pharmaceutical SciencesProfessor Ingunn Holen
Professor of Bone Oncology, The University of SheffieldDr Andreas Makris
Lead for Breast Cancer Research for the Mount Vernon Cancer CentreMairead MacKenzie
Patient AdvocateDr Adrienne Morgan
Chair of Trustees, Independent Cancer Patients’ Voice (ICPV)Professor Sarah Pinder
Chair of Breast Pathology, King's College LondonDr Sarah Vinnicombe
Consultant Radiologist, Thirlestaine Breast Centre, Cheltenham, and Honorary Senior Lecturer, University of Dundee
Keynote Speakers
Professor David Cameron
Edinburgh University Cancer Centre
Dr Judy Garber
Susan F. Smith Chair, Dana-Farber Cancer Institute Chief, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute Professor of Medicine, Harvard Medical School
Dr Martine Piccart
Honorary Professor of Oncology at the Université Libre de Bruxelles (ULB) and Scientific Director at the Jules Bordet Institute (Brussels/Belgium)
Dr Monica Morrow
Chief, Breast Service, Anne Burnett Windfohr Chair of Clinical Oncology Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Professor of Surgery Weill Medical College of Cornell University, USA
Dr Matthew Ellis
Director, Lester and Sue Smith Breast Centre, Baylor College Medicine, Professor of Medicine and Cellular and Molecular Biology, Houston, Texas, USA
Dr Philip Poortmans
Radiation Oncologist & Head of Department of Radiation Oncology, Marie Curie Professor Paris Science & Lettres, Institut Curie, Paris, France
Professor Eric Winer
Professor of Medicine, Harvard Medical School; Chief, Division of Breast Oncology, and the Thompson Chair in Breast Cancer Research, Dana-Farber Cancer Institute